HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Sílvia Cufí Selected Research

Mitogen-Activated Protein Kinase Phosphatases

1/2011Stem cell property epithelial-to-mesenchymal transition is a core transcriptional network for predicting cetuximab (Erbitux™) efficacy in KRAS wild-type tumor cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Sílvia Cufí Research Topics

Disease

25Neoplasms (Cancer)
01/2018 - 01/2011
13Breast Neoplasms (Breast Cancer)
01/2018 - 01/2011
6Carcinoma (Carcinomatosis)
05/2014 - 07/2011
3Carcinogenesis
05/2014 - 11/2011
2Type 2 Diabetes Mellitus (MODY)
05/2014 - 12/2011
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
10/2013 - 01/2013
2Neoplasm Metastasis (Metastasis)
04/2013 - 03/2012
2Ataxia Telangiectasia (Louis Bar Syndrome)
11/2011 - 05/2011
1Rectal Neoplasms (Rectal Cancer)
05/2014
1Skin Neoplasms (Skin Cancer)
05/2014
1Inflammation (Inflammations)
04/2014
1Stomach Neoplasms (Stomach Cancer)
04/2014
1Adenocarcinoma of Lung
07/2012
1Lung Neoplasms (Lung Cancer)
07/2012
1Starvation
07/2012
1Fibrosis (Cirrhosis)
02/2012
1Colorectal Neoplasms (Colorectal Cancer)
01/2011

Drug/Important Bio-Agent (IBA)

9Metformin (Glucophage)FDA LinkGeneric
09/2013 - 04/2011
7Pharmaceutical PreparationsIBA
01/2018 - 01/2011
5Trastuzumab (Herceptin)FDA Link
01/2013 - 01/2011
4BiguanidesIBA
05/2014 - 12/2011
4Proteins (Proteins, Gene)FDA Link
04/2014 - 07/2012
3Insulin (Novolin)FDA Link
05/2014 - 01/2013
3MicroRNAs (MicroRNA)IBA
01/2013 - 04/2011
3Erlotinib Hydrochloride (CP 358,774)FDA Link
01/2013 - 06/2011
3Hypoglycemic Agents (Hypoglycemics)IBA
07/2012 - 03/2012
2PhytochemicalsIBA
01/2018 - 06/2011
2Olive OilIBA
01/2018 - 06/2011
2Gefitinib (Iressa)FDA Link
10/2013 - 06/2011
2Silybin (Lagosa)IBA
10/2013 - 01/2013
2Phenobarbital (Luminal)FDA Link
09/2013 - 11/2012
2Phosphotransferases (Kinase)IBA
09/2013 - 07/2012
2IridoidsIBA
02/2013 - 06/2011
2Monoclonal AntibodiesIBA
01/2013 - 03/2012
2Glucose (Dextrose)FDA LinkGeneric
08/2012 - 07/2012
2EnzymesIBA
07/2012 - 01/2011
2Fatty Acid Synthases (Fatty Acid Synthase)IBA
07/2012 - 01/2011
2Lapatinib (GW572016)FDA Link
06/2011 - 01/2011
1Suppositories (Vaginal Suppositories)IBA
05/2014
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
05/2014
1Methotrexate (Mexate)FDA LinkGeneric
05/2014
1Estradiol (Delestrogen)FDA LinkGeneric
11/2013
1stage-specific embryonic antigen-4IBA
11/2013
1Estrogen ReceptorsIBA
11/2013
1Estrogens (Estrogen)FDA Link
11/2013
1Aldehyde DehydrogenaseIBA
11/2013
1SilymarinIBA
10/2013
1milk-thistle extractIBA
10/2013
1Tyrosine Kinase InhibitorsIBA
10/2013
1Amino SugarsIBA
10/2013
1MeglumineFDA Link
10/2013
1TOR Serine-Threonine KinasesIBA
09/2013
1Complement System Proteins (Complement)IBA
04/2013
1Staphylococcal Protein A (Protein A)IBA
01/2013
1ErbB Receptors (EGF Receptor)IBA
01/2013
1Cadherins (E-Cadherin)IBA
01/2013
1Chloroquine (Aralen)FDA LinkGeneric
01/2013
1Antimalarials (Antimalarial Agents)IBA
01/2013
1Transcription Factors (Transcription Factor)IBA
11/2012
1Oxygen (Dioxygen)IBA
08/2012
1AMP-Activated Protein KinasesIBA
08/2012
12- cyclohexylidenhydrazo- 4- phenyl- thiazoleIBA
07/2012
1Fatty Acids (Saturated Fatty Acids)IBA
07/2012
1PyrimidinesIBA
07/2012
1PurinesIBA
07/2012
1Folic Acid AntagonistsIBA
07/2012
1Folic Acid (Vitamin M)FDA LinkGeneric
07/2012
1ThymidineIBA
07/2012
1HypoxanthineIBA
07/2012
1CarbonIBA
07/2012
15,6,7,8-tetrahydrofolic acid (tetrahydrofolate)IBA
07/2012
1Succinate Dehydrogenase (Fumarate Reductase)IBA
03/2012
1DNA (Deoxyribonucleic Acid)IBA
03/2012
1Electron Transport Complex IV (Cytochrome c Oxidase)IBA
03/2012
1Receptor Protein-Tyrosine Kinases (Tyrosine Kinase Receptors)IBA
03/2012
1I-antigenIBA
03/2012
1Adenosine Triphosphate (ATP)IBA
03/2012
1Matrix Metalloproteinases (MMPs)IBA
07/2011
1LignansIBA
06/2011
1PhenolsIBA
06/2011
1Histones (Histone)IBA
06/2011
1PolyphenolsIBA
06/2011
1SurvivinIBA
04/2011
1RNA (Ribonucleic Acid)IBA
04/2011
1Biomarkers (Surrogate Marker)IBA
01/2011
1human ERBB2 proteinIBA
01/2011
1Cetuximab (Erbitux)FDA Link
01/2011
1Mitogen-Activated Protein Kinase PhosphatasesIBA
01/2011
11,3- bis((3,4,5- trihydroxybenzoyl)oxy)naphthaleneIBA
01/2011
1LigandsIBA
01/2011

Therapy/Procedure

8Therapeutics
05/2014 - 04/2011
1Diet Therapy (Therapy, Diet)
09/2013
1Subcutaneous Injections
12/2012
1Aftercare (After-Treatment)
04/2011